Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Cocktail & Poster Display session

27P - Analytical validation of a small amplicon NGS panel for MSI detection

Date

16 Oct 2024

Session

Cocktail & Poster Display session

Presenters

Alexandra Lebedeva

Citation

Annals of Oncology (2024) 9 (suppl_6): 1-20. 10.1016/esmoop/esmoop103740

Authors

A. Lebedeva1, A. Taraskina2, A. Kavun2, T. Grigoreva2, E. Belova2, L. Belyaeva1, O.A. Kuznetsova3, D.A. Kravchuk4, A. Barinov5, E. Ignatova6, V. Nikulin7, V. Mileyko2, A. Tryakin3, M. Fedyanin4, M. Ivanov2

Author affiliations

  • 1 Laboratory Of Applied Genomics, Sechenov University, 119048 - Moscow/RU
  • 2 OncoAtlas LLC, 119049 - Moscow/RU
  • 3 Chemotherapy Dept., N.N.Blokhin Russian Cancer REsearch Center, 115478 - Moscow/RU
  • 4 State Budgetary Institution of Healthcare of the City of Moscow "Moscow Multidisciplinary Clinical Center "Kommunarka" of the Department of Health of the City of Moscow, Moscow, Russia, 142770 - Moscow/RU
  • 5 Moscow Municipal Oncology Hospital No. 62, 125130 - Moscow/RU
  • 6 STOONCO: Science and Technology in Oncology, 121108 - Moscow/RU
  • 7 National Medical Research Center of Oncology named after N.N. Blokhin, 115478 - Moscow/RU

Resources

This content is available to ESMO members and event participants.

Abstract 27P

Background

With the development of immune checkpoint inhibitors (ICI), microsatellite instability (MSI) has become an important biomarker. While large multigene hybrid capture next-generation sequencing (NGS) panels are highly accurate in detecting MSI, the sensitivity of small amplicon-based panels is unknown.

Methods

Next-generation sequencing (NGS) was performed on FFPE samples from patients with any stage colorectal cancer (CRC) using the Solo Atlas Pro amplicon panel covering 38 genes and 39 mononucleotide short tandem repeats for MSI analysis. 5-loci polymerase chain reaction (PCR)-based MSI analysis was used as a reference method. MSI by NGS was estimated based on the distribution of k-mers. Statistical analysis was performed using Cohen’s kappa (к), Mann Whitney and Fisher’s exact test.

Results

A total of 160 samples were analyzed using NGS and PCR. Median coverage was 2352x (range, 238-28447х), MAPD – 0.368 (range, 0.236-0.731). Based on PCR results, 42 (46.25%) samples were MSI, 118 (73.75%) – MSS. Based on NGS results, 40 (25%) samples were MSI, 120 (75%) were MSS. NGS and PCR were concordant in 98.75% (158/160) of samples (к=0.97). Sensitivity of NGS was 95.24% (95% CI, 83.84%-99.42%), specificity – 100.00% (96.92%-100.00%), accuracy – 98.75% (95.56%-99.85%). All NGS false positives cases had suboptimal FFPE quality, suggested by absence of any somatic mutations identified. MSI samples had a significantly higher amount of somatic mutations than MSS samples (median, 3 vs 1, p<0.0001). In silico mixing of the sequencing data of 11 MSI samples demonstrated that the minimal sample fraction with the detectable MSI was 0.5%; at 2.5% MSI was detectable in all samples.

Conclusions

The Atlas Pro amplicon panel demonstrates high concordance with PCR and is highly sensitive in detecting MSI in CRC samples.

Editorial acknowledgement

Clinical trial identification

Legal entity responsible for the study

The authors.

Funding

Russian Science Foundation (Grant №22-75-10154).

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.